07:33 AM EST, 02/19/2025 (MT Newswires) -- Amicus Therapeutics ( FOLD ) reported Q4 non-GAAP earnings Wednesday of $0.09 per diluted share, up from $0.01 a year earlier.

Analysts polled by FactSet expected $0.10.

Net product revenue for the quarter that ended Dec. 31 was $149.7 million, up from $115.1 million a year earlier.

Analysts surveyed by FactSet expected $147.9 million.

Shares were up more than 1% in recent premarket activity Wednesday.